BBS financial manager Annastiina Kauppinen resigns
She will continue until March 7, 2025. CEO thanks her for contributions to financial and HR management.
See the latest news and media coverage for BBS. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of bioactive bone graft substitutes
bbs-artebone.fiLast updated
In short: BBS-Bioactive Bone Substitutes' CEO left, bankruptcy estate halted reports and board members were fined.
She will continue until March 7, 2025. CEO thanks her for contributions to financial and HR management.
The Board negotiates with shareholders for additional funding to ensure short-term financing and working capital.
The authority fined Pekka Jalovaara €4,000, Jarmo Halonen €5,000, and former member Ahti Paananen €9,000 for late transaction notifications. The decision is appealable.
The bankruptcy estate will not publish the 2024 financial statement release or other previously announced statements.
The company's loan negotiations have ended without results, so securing funding and continuing the company's operations is impossible. - Despite extensive efforts to find a sustainable financial and operational solution...
(MENAFN- GlobeNewsWire - Nasdaq) BBS-Bioactive Bone Substitutes Plc, press release, 25 November 2023 at 11.00 a.m. BBS-Bioactive Bone Substitutes Plc ("BBS") has received confirmation from...
BBS-Bioactive Bone Substitutes Plc | Company Release | February 17, 2025 at 13:15:00 EET BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc...
Get more content for free, follow topics that interest you and save articles to read later. Log in Create new Alma account Can you play a nasty trick on a child in inheritance division...
Track BBS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.